Procurement contracts for COVID-19 vaccines

Contracts for the procurement of COVID-19 vaccines are disclosed here once negotiations with the manufacturers have been concluded.

To protect the population, the federal government procured vaccines from different manufacturers at an early stage. It was thus able to give members of the Swiss public quick access to safe, effective COVID-19 vaccines. The main emphasis was on mRNA vaccines, supplemented with other vaccines.

The contracts for the procurement of COVID-19 vaccines are disclosed in line with the requirements of the Federal Freedom of Information Act (FoIA/BGö/LTrans), which protects the manufacturers’ professional, trade and manufacturing secrets. These include details of their business strategy or the calculation of prices. This information has been blacked out in the documents.

All contracts and agreements are written in English and are only available in that language.

Contracts

Federal Office of Public Health FOPH

Legal Affairs Division
Schwarzenburgstrasse 157
Switzerland - 3003 Bern

recht@bag.admin.ch

Show location on map

Procurement contracts for COVID-19 vaccines

Contracts

Moderna Switzerland GmbH

Agreement: Memorandum of Understanding

Memorandum of Understanding_9.6.20

Agreement: Agreement

Agreement_5.8.20

Agreement: Parent Guarantee Agreement

Parent Guarantee Agreement_5.8.20

Agreement: First Amendment

First Amendment_4.12.20

Agreement: Amended Parent Guarantee Agreement

Amended Parent Guarantee Agreement_4.12.20

Agreement: Second Amendment

Second Amendment_2.2.21

Agreement: Third Amendment

Third Amendment_5.5.21

Agreement: Purchase Contract No 1

Purchase Contract No 1_5.5.21

Agreement: Purchase Contract No 1 Parent Guarantee Agreement

Purchase Contract No1 Parent Guarantee Agreement_5.5.21

Agreement: Fourth Amendment

Fourth Amendment _18.3.22

Agreement: Purchase Contract No 2

Purchase Contract No 2_18.3.22

Pfizer AG

Agreement: Head of Terms

Head of Terms_12.10.20

Agreement: Manufacturing and Supply Agreement

Manufacturing and Supply Agreement_1.12.20

Agreement: Amendment to Manufacturing and Supply Agreement

Amendment to Manufacturing and Supply Agreement

Agreement: Second Amendment to Manufacturing and Supply Agreement

Second Amendment to Manufacturing and Supply Agreement_23.8.21

Agreement: Third Amendment to Manufacturing and Supply Agreement

Third Amendment to Manufacturing and Supply Agreement_22.12.21

Agreement: Shipping and Handling Guidelines

Shipping and Handling Guidelines_22.12.21

Novavax Inc. USA

Agreement: Head of Terms

Heads of Terms_11._12.1.2021

Agreement: Advance Purchase Agreement

Advance Purchase Agreement_3.12.21

Agreement: Accession Agreement

Accession Agreement_3.12.21

Janssen Pharmaceutica NV

Agreement: Bilateral Agreement Frankreich – Schweiz

Bilateral Agreement Frankreich - Schweiz_28.9.21

Agreement: Supplemental Agreement Janssen – Schweiz

Supplemental Agreement Janssen - Schweiz_24.9.21

Agreement: Letter Consent to envisaged resale

Letter Consent to envisaged resale_27.9.21

AstraZeneca AG

Agreement: Advance Purchase Agreement Schweden -AstraZeneca - Schweiz

Advance Purchase Agreement SWE-AstraZeneca-CH_15.10.20

Agreement: Resell Agreement Schweden - Schweiz

Resell Agreement SWE - CH_15.10.20

CureVac Corporate Services GmbH

Agreement: Three-Party Agreement Schweden – Curevac - Schweiz

Three-Party Agreement Schweden - Curevac - Schweiz_3.2.21

Agreement: Resell Agreement Schweden - Schweiz

Resell Agreement Schweden - Schweiz_3.2.21

Federal Office of Public Health FOPH